Back to results
US 2013/0296308 A1Published application
Heterocyclic Substituted Hexahydropyrano[3,4-d][1,3]Thiazin-2-Amine Compounds
AssigneePfizer Inc.
InventorsMichael Aaron Brodney, Christopher Ryan Butler, Elizabeth Mary Beck, Jennifer Elizabeth Davoren, Brian Thomas O'Neill
Life of this patent
Estimating the term…
Abstract
Compounds, tautomers and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I, as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
Claims21
A compound having the absolute stereochemistry of Formula I
- wherein
- R1 is hydrogen or methyl, wherein said methyl is optionally substituted with one to three fluoro;
- R2 is a 5- to 6-membered heteroaryl, having one to three heteroatoms selected from N, O or S, wherein at least one of the heteroatoms is S or N and wherein said N is optionally substituted with R4;
- and wherein said heteroaryl moiety is independently substituted at each available carbon position with R3a, R3b, R3c or R3d;
- R3a, R3b, R3c and R3d are independently hydrogen, halogen, —OH, —CN, C1-6alkyl, —OC1-6alkyl;
- —(CR5aR5b)m—C3-6cycloalkyl or —(CR5aR5b)m—C3-6heterocycloalkyl;
- wherein said alkyl is optionally substituted with one to three fluoro and wherein said cycloalkyl and heterocycloalkyl moieties are optionally substituted with one to three fluoro, —CH3, —CH2F, —CHF2 or —CF3;
- R4 is hydrogen, C1-6alkyl, or —(CR5aR5b)m—C3-6cycloalkyl;
- wherein said alkyl and cycloalkyl are optionally substituted with one to three fluoro, —OCH3 or —OCF3;
- R5a and R5b are independently hydrogen, —CH3, —CH2F, —CHF2, —CF3 or —OCH3;
- and
- m is 0, 1 or 2;
- or a tautomer thereof or a pharmaceutically acceptable salt of said compound or tautomer.
10 more elements
-25. (canceled)
Dependencies are inferred from the claim text.